Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas

Histopathology

Volumn 55, Issue 3, 2009, Pages 250-260

  Zhang, Xiaojun ^a   Wang, Yang ^a   Yamamoto, Gou ^a   Tachikawa, Tetsuhiko ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Epithelium; Laser microdissection; Matrix metalloproteinases; Pleomorphic adenoma; Real time reverse transcription polymerase chain reaction; Stroma; Tissue inhibitor of metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; MALE; MYOEPITHELIUM; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND TUMOR; STROMA;

ADENOMA, PLEOMORPHIC; ADULT; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PAROTID GLAND; RNA, MESSENGER; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS, MINOR; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 69549116698     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03355.x     Document Type: Article

References (43)

1. Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution and diversification. FASEB J. 1998 12 1075 1095.
2. Johansson N, Ahonen M, Kähäri VM. Matrix metalloproteinases in tumor invasion. Cell. Mol. Life Sci. 2000 57 5 15.
3. Liotta LA, Steeg PA, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991 64 327 336.
4. Bishop JE, Greenbaum R, Gibson DG, Yacoub M, Laurent G. Enhanced deposition of predominantly type I collagen in myocardial disease. J. Mol. Cell. Cardiol. 1990 22 1157 1165.
5. Emonard HP, Remacle AG, Noel AC, Grimaud JA, Stetler-Stevenson WG, Foidart JM. Tumor cell surface-associated binding site for the Mr 72, 000 type IV collagenase. Cancer Res. 1992 52 5845 5848.
6. Mook ORF, Frederiks WM, Van Noorden CJF. The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta 2004 1705 69 89.
7. Montgomery AMP, Mueller BM, Reisfeld RA, Taylor SM, Declerck YA. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res. 1994 54 5467 5473.
8. Charous SJ, Stricklin GP, Nanney LB, Netterville JL, Burkey BB. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann. Otol. Rhinol. Laryngol. 1997 106 271 278.
9. Heppner Gross KJ, Brown PD, Matrisian LM. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorgenesis. Int. J. Cancer 1998 78 629 635.
10. Klijanienko J, El-Naggar AK, Servois V, Rodriguez J, Validire P, Vielh P. Clinically aggressive metastasizing pleomorphic adenoma: report of two cases. Head Neck 1997 19 629 633.
11. Henriksson G, Westrin KM, Carlsöö B, Silfverswärd C. Recurrent primary pleomorphic adenomas of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia. Cancer 1998 82 617 620.
12. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol. Annu. 1993 28 279 328.
13. Brandwein MS, Huvos AG, Dardick I, Thomas MJ, Theise ND. Noninvasive and minimally invasive carcinoma ex mixed tumour: a clinicopathologic and ploidy study of 12 patients with major salivary tumours of low (or no?) malignant potential. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1996 81 655 664.
14. Bissell MJ, Radisky D. Putting tumours in context. Nat. Rev. Cancer 2001 1 46 54.
15. Auclair PL, Ellis GL. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Mod. Pathol. 1996 9 652 657.
16. Seifert G, Langrock I, Donath K. A pathological classification of pleomorphic adenoma of the salivary glands. HNO 1976 24 415 426.
17. Irié T, Aida T, Aida M et al. Laser pressure cell transfer method: a new microdissection technique for frozen sections. Oral. Med. Pathol. 2004 9 53 60.
18. Pyke C, Ralfkiaer E, Tryggvason K, Dano K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol. 1993 142 359 365.
19. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001 411 375 379.
20. Wernert N. The multiple roles of tumor stroma. Virchows Arch. 1997 430 433 443.
21. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum. Pathol. 2001 32 596 604.
22. Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck 2001 23 705 712.
23. Yoshihara T, Tanaka M, Itoh M, Ishii T. Carcinoma ex pleomorphic adenoma of the soft palate. J. Laryngol. Otol. 1995 109 240 243.
24. Diaz NM, McDivitt RW, Wick MR. Pleomorphic adenoma of the breast: a clinicopathologic and immunohistochemical study of 10 cases. Hum. Pathol. 1991 22 1206 1214.
25. Chilla R, Schneider K, Droese M. Recurrence tendency and malignant transformation of pleomorphic adenomas. HNO 1986 34 467 469.
26. Nagel H, Laskawi R, Wahlers A, Hemmerlein B. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland. Histopathology 2004 44 222 231.
27. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 2001 17 463 516.
28. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002 2 161 174.
29. Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev. 2003 22 145 152.
30. Xu X, Wang Y, Chen Z, Sternlicht MD, Hidalgo M, Steffensen B. Matrix metalloproteinase-2 contributes to cancer cell migration on collagen. Cancer Res. 2005 65 130 136.
31. Ring P, Johansson K, Höyhtyä M, Rubin K, Lindmark G. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer: a predictor of tumour stage. Br. J. Cancer 1997 76 805 811.
32. Canete-Soler R, Litzky L, Lubensky I, Muschel RJ. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am. J. Pathol. 1994 144 518 527.
33. McCarthy K, Maguire T, McGreal G, McDermott E, O'Higgins N, Duffy MJ. High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer. Int. J. Cancer 1999 84 44 48.
34. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J. Cell Sci. 1994 107 2373 2379. (Pubitemid 24292486)
35. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J. Natl Cancer Inst. 1992 84 1017 1022.
36. Krecicki T, Fraczek M, Jelen M, Podhorska M, Szkudlarek T, Zatonski T. Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas. Eur. Arch. Otorhinolaryngol. 2003 260 494 497.
37. Azuma M, Tamatani T, Fukui K et al. Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase-1 in the metastatic process of human salivary-gland adenocarcinoma cells. Int. J. Cancer 1993 54 669 676.
38. Jinga DC, Blidaru A, Condrea I et al. MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors. J. Cell Mol. Med. 2006 10 499 510.
39. Onisto M, Riccio MP, Scannapieco P et al. Gelatinase A/TIMP-2 imbalance in lymph-node-positive breast carcinomas, as measured by RT-PCR. Int. J. Cancer 1995 63 621 626.
40. Macabeo-Ong M, Ginzinger DG, Dekker NP et al. Effect of formalin fixation time on tissues for quantitative mRNA expression analysis. Mod. Pathol. 2002 15 979 987.
41. Sheu BC, Lien HC, Ho HN et al. Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res. 2003 63 6537 6542.
42. Yoshizaki T, Maruyama Y, Sato H, Furukawa M. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int. J. Cancer 2001 95 44 50.
43. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 2001 17 463 516.